CINECA IRIS Institutional Research Information System

MARCOCCI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.694
AS - Asia 16.169
EU - Europa 11.407
SA - Sud America 2.701
AF - Africa 785
Continente sconosciuto - Info sul continente non disponibili 718
OC - Oceania 26
Totale 67.500
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.740
SG - Singapore 4.933
CN - Cina 4.290
IT - Italia 3.300
HK - Hong Kong 2.857
BR - Brasile 2.233
SE - Svezia 2.070
VN - Vietnam 1.540
DE - Germania 1.128
BG - Bulgaria 1.051
CA - Canada 691
GB - Regno Unito 691
TR - Turchia 669
FR - Francia 645
RU - Federazione Russa 530
FI - Finlandia 520
UA - Ucraina 478
KR - Corea 386
AT - Austria 377
IN - India 368
CI - Costa d'Avorio 273
JP - Giappone 220
CH - Svizzera 178
BD - Bangladesh 165
AR - Argentina 149
SN - Senegal 126
IQ - Iraq 109
ZA - Sudafrica 97
MX - Messico 96
ID - Indonesia 92
NL - Olanda 82
SA - Arabia Saudita 82
EC - Ecuador 81
PK - Pakistan 70
UZ - Uzbekistan 69
PL - Polonia 65
MA - Marocco 61
CO - Colombia 59
BE - Belgio 57
VE - Venezuela 57
ES - Italia 53
EG - Egitto 47
NG - Nigeria 44
KE - Kenya 39
PY - Paraguay 33
PH - Filippine 32
JO - Giordania 29
DZ - Algeria 28
JM - Giamaica 27
CL - Cile 26
CR - Costa Rica 26
NP - Nepal 26
CZ - Repubblica Ceca 24
UY - Uruguay 22
AU - Australia 21
AZ - Azerbaigian 20
DO - Repubblica Dominicana 20
IE - Irlanda 20
IL - Israele 20
MY - Malesia 20
PE - Perù 20
AE - Emirati Arabi Uniti 18
LB - Libano 18
BO - Bolivia 16
PS - Palestinian Territory 15
RO - Romania 15
TN - Tunisia 14
GR - Grecia 13
KZ - Kazakistan 13
LT - Lituania 13
TH - Thailandia 13
TT - Trinidad e Tobago 13
AL - Albania 12
BB - Barbados 12
ET - Etiopia 12
EU - Europa 12
HU - Ungheria 11
KG - Kirghizistan 11
LV - Lettonia 11
OM - Oman 11
RS - Serbia 11
HN - Honduras 10
NI - Nicaragua 10
DK - Danimarca 9
IR - Iran 9
PA - Panama 9
BJ - Benin 8
BS - Bahamas 8
GE - Georgia 8
PT - Portogallo 8
GT - Guatemala 7
SK - Slovacchia (Repubblica Slovacca) 7
SV - El Salvador 7
BH - Bahrain 6
KW - Kuwait 6
QA - Qatar 6
SY - Repubblica araba siriana 6
TW - Taiwan 6
BW - Botswana 5
CG - Congo 5
Totale 66.686
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.472
Ashburn 3.405
Hong Kong 2.816
Fairfield 2.769
Singapore 2.674
Houston 2.128
Ann Arbor 2.069
Dallas 1.750
Chandler 1.739
San Jose 1.528
Santa Clara 1.506
Seattle 1.167
Sofia 1.050
Wilmington 996
Shanghai 980
Cambridge 925
Beijing 891
Milan 878
New York 813
Jacksonville 543
Ottawa 517
Boardman 513
Serra 511
Los Angeles 501
Hefei 497
Princeton 462
Lawrence 433
Medford 393
Ho Chi Minh City 387
Seoul 371
Lauterbourg 355
Vienna 330
Nanjing 293
Izmir 281
Abidjan 273
Hanoi 273
Des Moines 268
Istanbul 251
Munich 246
Florence 229
Dearborn 208
Dong Ket 205
Tokyo 201
London 178
São Paulo 178
Council Bluffs 176
Buffalo 167
San Diego 157
Redondo Beach 155
Bern 153
Frankfurt am Main 150
Helsinki 131
Dakar 123
Rome 122
Nanchang 120
Jüchen 113
Atlanta 111
Pisa 110
Bremen 97
Orem 89
Chicago 88
Lancaster 86
Redwood City 84
Ogden 80
Rio de Janeiro 74
Düsseldorf 71
Kunming 69
San Francisco 69
Marseille 66
Brooklyn 64
Turku 64
Boulder 63
Columbus 63
Hebei 61
Shenyang 61
Tashkent 61
Da Nang 60
The Dalles 58
Changsha 56
Phoenix 56
Brussels 54
Denver 54
Piscataway 54
Montreal 53
Norwalk 53
Washington 51
Belo Horizonte 47
Kocaeli 46
Fuzhou 45
Tianjin 45
Baghdad 44
Haiphong 44
Guangzhou 43
Johannesburg 42
Dhaka 41
Falls Church 38
Hyderabad 37
Jiaxing 37
Nuremberg 36
Warsaw 36
Totale 46.681
Salva come PNG Salva come JPEG
Nome #
Changes of circulating thyroid autoantibody levels during and after therapy with methimazole in patients with Graves’ disease 555
Complicanze chirurgiche in pazienti sottoposti a decompressione orbitaria per oftalmopatia di Graves [Surgical complications in orbital decompression for Graves’ orbitopathy] 455
Natural history of graves’ orbitopathy after treatment 452
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 390
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 377
Thyroid directed antibodies 367
Thyroid imaging in the management of anti-PD1/PD-L1 induced thyrotoxicosis 358
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 345
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study 326
Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy 299
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy 293
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy 266
Primary hyperparathyroidism 255
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 254
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 249
A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases 248
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 246
Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial 229
Clinical profile of juvenile primary hyperparathyroidism: a prospective study 229
1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth 228
Sortilin is a putative post-endocytic receptor of thyroglobulin 227
Management of thyrotoxicosis induced by PD1 or PD-L1 blockade 227
Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone 225
Parathyroid Carcinoma and Adenoma Co-existing in One Patient: Case Report and Comparative Proteomic Analysis 225
Neuropsychological assessment in schoolchildren from an area of moderate iodine deficiency 224
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? 222
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 219
First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation. 217
Advances in the clinical management of parathyroid disorders: report from the 2024 workshop by the ESE educational program on parathyroid disorders 216
A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer 215
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 214
Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. 209
A new mutation of the MEN1 gene in an italian kindred with multiple endocrine neoplasia type 1 208
A proteomic approach to study parathyroid glands 206
Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas 206
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 204
Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts 204
Association of the changes in cytosolic Ca2+ and iodide efflux induced by thyrotropin and by the stimulation of alpha 1-adrenergic receptors in cultured rat thyroid cells 203
Norepinephrine and thyrotropin stimulation of iodide efflux in FRTL-5 thyroid cells involves metabolites of arachidonic acid and is associated with the iodination of thyroglobulin 203
Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I 203
Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism 203
Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy 200
A 70-year-old woman with Bilateral Orbital Infiltrative disease. 200
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis 200
Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST 199
Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling. 199
Non-surgical management of primary hyperparathyroidism 199
Graves' Disease Induced by Immune Checkpoint Inhibitors: A case report and Review of the literature 199
More on smoking habits and Graves' ophthalmopathy 198
TSH-Dependent Expression of the LDL Receptor-Associated Protein (RAP) in Thyroid Epithelial Cells 198
Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease 197
Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis 197
Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center 197
The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis 194
Hereditary hypercalcemia caused by a homozygous pathogenic variant in the cyp24a1 gene: A case report and review of the literature 194
TSH-Dependent expression of the LDL receptor-associated protein (RAP) in thyroid epithelial cells 193
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 193
Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease. 191
Sodium/proton exchange in the maintenance of intracellular pH in FRTL-5 thyroid cells 191
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 191
Effect of actinomycin D on iodide transport in FRTL-5 thyroid cells 190
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 190
Agretti P, De Marco G, De Servi M, Marcocci C, Vitti P, Pinchera A, Tonacchera M.: Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation 188
Outcome of Graves' Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 188
Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO) 188
Six novel MEN1 gene mutations in sporadic parathyroid tumors 188
Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with graves’ ophthalmopathy 187
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation 187
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement 187
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 186
Calcium-sensing receptor gene polymorphism is not associated with bone mineral density in Italian postmenopausal women 185
Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation 182
Demonstration and organ distribution of the 1,25-dihydroxyvitamin D3-binding protein in fish (A. anguilla) 181
Optic neuropathy in 2 thyroidectomized patients with moderate to severe Graves’ ophthalmopathy following L-thyroxine withdrawal prior to radioiodine treatment for thyroid carcinoma 181
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases 181
Whole exome sequencing in familial isolated primary hyperparathyroidism 180
Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism 179
Exome analysis of a large family with Familial Isolated Primary Hyperparathyroidism (FIHP) and multiple cancers. 179
THERAPEUTIC CONTROVERSIES. RADIOIODINE MAY BE BAD FOR GRAVES’ OPHTHALMOPATHY , BUT…… 178
Direct Determination of Tetrahydrocortisol and Tetrahydrocortisone in Urine Samples from Patients under Steroid Drugs Treatment by LC-MS-MS 178
Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival 178
Occurrence of Graves’ Orbitopathy and of Graves’ hyperthyroidism after a trauma to the eye 177
Risk factors for renal calcifications and determinants of hypercalciuria in patients with chronic, post-surgical hypoparathyroidism 177
Role of thyroglobulin in the pathogenesis of Graves’ ophthalmopathy: the hypothesis of Kriss revisited 176
A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (Aip) gene in an Italian family with gigantism 176
Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves’ orbitopathy 176
Come definire lo status della vitamina 25OHD: aspetti metodologici (laboratorio) e clinici (VDBP, free 25OHD, bioavailable 25(OH)D) 176
Chirurgia dello strabismo nella oftalmopatia endocrina. 174
Studies on the occurrence of ophthalmopathy in Graves' disease 174
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy 174
Familial hypocalciuric hypercalcemia type 1 due to a novel homozygous mutation of the calcium-sensing receptor gene 174
Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study 174
Orbital radiotherapy in the treatment of endocrine ophthalmopathy: when and why 173
Cytokine antagonists: new ideas for the management of Graves' ophthalmopathy 173
Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated 173
a novel germline mutation of men 1 gene in a patient with acromegaly and multiple endocrine tumors 173
Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients 173
Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices 172
Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors? 172
The PRIMARA study: A prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice 172
Totale 21.801
Salva come PNG Salva come JPEG
Categoria #
all - tutte 198.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 198.252
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.861 0 251 119 376 919 653 124 237 324 312 274 1.272
2022/20235.791 727 746 430 433 650 770 47 453 1.058 29 387 61
2023/20243.935 494 415 545 219 561 708 163 138 54 28 197 413
2024/202513.330 66 502 188 698 1.211 1.155 1.077 766 1.400 1.781 1.500 2.986
2025/202615.528 1.107 2.109 2.181 1.735 1.386 1.303 1.982 682 727 1.269 474 573
2026/20272.523 980 1.543 0 0 0 0 0 0 0 0 0 0
Totale 67.500